Ledger.

Director of Commercialisation, Uniservices

Evelyn Body

Coverage

Stories naming Evelyn Body. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

2 deals

Over $15m invested in world-leading cancer immunotherapy

Auckland University spinout TamoRx has secured NZ$15.25 million to develop a new cancer immunotherapy, in a round led by Brandon Capital alongside the university's Inventors' Fund, with a Callaghan Innovation grant included.

Brandon Capital portfolio Mon 6 Jun 2022 Brandon BioCatalystMana CommunicationsUniservicesUniversity of AucklandBrandon CapitalCallaghan InnovationUniversity of Auckland Inventors' FundDuncan MackintoshEvelyn BodyProfessor Rod Dunbar

Something wrong? Tell us